Stay updated on Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial
Sign up to get notified when there's something new on the Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial page.

Latest updates to the Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0; no visible changes to the study details.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.4.3 replaces v3.4.2. No visible changes to the study details or navigation are apparent in the screenshot.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 is visible, with no changes to the study content or layout observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page update is a minor template revision from v3.4.0 to v3.4.1. It does not affect core study content, eligibility criteria, outcomes, or listed locations.SummaryDifference0.0%

- Check67 days agoChange DetectedNo significant changes detected between the two screenshots; the page content and layout appear unchanged.SummaryDifference0.0%

- Check74 days agoChange DetectedGlossary visibility controls were added (Show glossary / Hide glossary). The page revision label was updated to Revision: v3.4.0, and capitalization changes were applied to related labels (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data').SummaryDifference0.2%

Stay in the know with updates to Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial page.